Source-grounded facts extracted from Rafael Holdings, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Rafael Holdings, Inc. reported the nine months ended April 30, 2026 results: net income net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share, EPS $0.40 per share.
“For the nine months ended April 30, 2026, we recorded a net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share, versus a net loss of $18.4 million, or $0.73 per share in the year ago period.”
Rafael Holdings, Inc. reported the fiscal quarter ended April 30, 2026 results: net income net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share, EPS $0.08 per share.
“For the three months ended April 30, 2026, we recorded a net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share, versus a net loss of $4.8 million, or $0.19 per share in the year ago period.”
Rafael Holdings, Inc. reported the six months ended January 31, 2026 results: net income $16.2 million, EPS $0.32 per share.
“For the six months ended January 31, 2026, we recorded a net loss attributable to Rafael Holdings of $16.2 million, or $0.32 per share”
Rafael Holdings, Inc. reported the three months ended January 31, 2026 results: net income $6.4 million, EPS $0.13 per share.
“For the three months ended January 31, 2026, we recorded a net loss attributable to Rafael Holdings of $6.4 million, or $0.13 per share”
Rafael Holdings, Inc.: Adopted Fourth Amended and Restated By-Laws adding ex-officio (non-voting) directors and authorizing vice chairman position, with corresponding changes to various articles and sections (effective 2025-07-14).
“On July 14, 2025, the Board of Directors of the Company adopted the Company’s Fourth Amended and Restated By-Laws, effective as of July 14, 2025, with the effect of adding ex-officio (non-voting) directors (in addition to voting directors) to the Board and authorizing the officer position of vice chairman and making corresponding changes to the following Articles and Sections: ● Article III, Sections 1, 2, 3, 4, 5, 6, 8, and 11. ● Article IV, Section 1. ● Article IX.”
Howard Jonas was appointed as Chief Executive Officer and President at Rafael Holdings, Inc..
“On April 23, 2025, the Company’s Board of Directors elected Howard Jonas, the Company’s Executive Chairman and Chairman of the Board, as the Company’s Chief Executive Officer and President, effective June 1, 2025.”
William Conkling resigned as Chief Executive Officer and President at Rafael Holdings, Inc..
“On April 23, 2025, William Conkling resigned as Chief Executive Officer and President of Rafael Holdings, Inc. (the “Company”), effective May 31, 2025.”
Rafael Holdings, Inc. completed an acquisition involving Cyclo Therapeutics, Inc. (closed 2025-03-25).
“On March 25, 2025, Rafael Holdings, Inc., a Delaware corporation (“Rafael”), completed the previously announced business combination transaction with Cyclo Therapeutics, Inc., a Nevada corporation (“Cyclo”) contemplated by that certain Agreement and Plan of Merger, dated as of August 21, 2024”
Markus W. Sieger was appointed as Director at Rafael Holdings, Inc..
“On March 25, 2025, effective as of the Effective Time, Markus W. Sieger, former Chairman of the Board of Cyclo, was appointed as a member of the Board.”
Mark N. Stein was elected as Director at Rafael Holdings, Inc..
“On August 5, 2024, Mark N. Stein, MD was elected as a director of Rafael Holdings, Inc. and elected as a member of the Company’s Board of Directors Audit, Compensation and Corporate governance committees.”
Mark McCamish resigned as Director at Rafael Holdings, Inc..
“On August 5, 2024, Mark McCamish resigned as director of Rafael Holdings, Inc., effective immediately.”
Rafael Holdings, Inc. reported second quarter of fiscal 2024 results: net income net income from continuing operations of $5.9 million, EPS $0.25 per fully diluted share.
“For the three months ended January 31, 2024, we recorded net income from continuing operations of $5.9 million, or $0.25 per fully diluted share”
Rafael Holdings, Inc. shareholders rejected Advisory vote on frequency of future advisory votes on executive compensation at the 2024-01-10 meeting.
“One Year Two Years Three Years Broker Non-Vote % Votes For 190,782 11,291 3,437,263 481,138 N/A”
Rafael Holdings, Inc. shareholders approved Advisory vote on named executive officer compensation at the 2024-01-10 meeting.
“Votes For Votes Against Abstentions Broker Non-Vote % Votes For 3,598,791 12,916 28,704 481,138 87.32”
Rafael Holdings, Inc. shareholders approved Ratification of CohnReznick LLP as independent registered public accounting firm at the 2024-01-10 meeting.
“Votes For Votes Against Abstentions Broker Non-Vote % Votes For 4,109,091 1,673 10,786 0 99.70”
Rafael Holdings, Inc. shareholders approved Election of directors at the 2024-01-10 meeting.
“Susan Y. Bernstein 3,631,422 7,558 1,432 481,138 88.11 Stephen M. Greenberg 3,567,480 71,108 1,824 481,138 86.56 Howard S. Jonas 3,561,682 77,309 1,422 481,138 86.42 Mark A. McCamish 3,567,810 71,174 1,423 481,142 86.56 Michael J. Weiss 3,511,327 127,645 1,440 481,138 85.19”
Rafael Holdings, Inc. reported first quarter of fiscal 2024 - the three months ended October 31, 2023 results: net income net loss from continuing operations of $3.8 million, or $0.15 per share, EPS $0.15 per share.
“Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results”
Rafael Holdings, Inc. reported the twelve months ended July 31, 2023 results: net income a net loss from continuing operations of $8.7 million, or $0.36 per share, EPS $0.36 per share.
“For the twelve months ended July 31, 2023, we incurred a net loss from continuing operations of $8.7 million, or $0.36 per share.”
Rafael Holdings, Inc. reported the three months ended July 31, 2023 results: net income $1.3 million, or $0.06 per share, EPS $0.06 per share.
“For the three months ended July 31, 2023, we incurred net income from continuing operations of $1.3 million, or $0.06 per share.”
Rachel Jonas resigned as Director at Rafael Holdings, Inc..
“On October 25, 2023, Rachel Jonas resigned as director of Rafael Holdings, Inc., effective immediately.”
Boris Pasche resigned as director at Rafael Holdings, Inc..
“On August 7, 2023, Dr. Boris Pasche, in connection with a change in his principal employment, resigned as director of Rafael Holdings, Inc. (the “Company”).”
Rafael Holdings, Inc. reported the third quarter of fiscal 2023 for the three months ended April 30, 2023 results: net income net loss from continuing operations of $1.5 million, or $0.06 per share, EPS $0.06 per share.
“Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update”
Rafael Holdings, Inc. reported the six months ended January 31, 2023 results: net income net loss from continuing operations of $8.5 million, EPS $0.36 per share.
“For the six months ended January 31, 2023, we incurred a net loss from continuing operations of $8.5 million, or $0.36 per share.”
Rafael Holdings, Inc. reported the three months ended January 31, 2023 results: net income net loss from continuing operations of $3.3 million, EPS $0.13 per share.
“For the three months ended January 31, 2023, we incurred a net loss from continuing operations of $3.3 million, or $0.13 per share.”
Patrick Fabbio departed as Chief Financial Officer at Rafael Holdings, Inc..
“In connection with Patrick Fabbio’s departure as Chief Financial Officer as previously disclosed in the Prior 8-K, on January 5, 2023, the Company and Mr. Fabbio entered into a Separation and General Release Agreement”
Rafael Holdings, Inc. shareholders approved Approval of the amendment to the 2021 Equity Incentive Plan that will, among other things, increase the number of shares of the Company’s Class B common stock available for the grant of awards thereunder by an additional 696,770 at the 2023-01-23 meeting.
“Votes For Votes Against* Broker Non-Vote % Votes For 3,341,908 203,090 427,807 84.02”
Rafael Holdings, Inc. shareholders approved Ratification of the appointment of CohnReznick LLP as the Company’s independent registered public accounting firm for the Fiscal Year ending July 31, 2023 at the 2023-01-23 meeting.
“Votes For Votes Against Abstentions Broker Non-Vote % Votes For 3,958,623 17,797 880 0 99.53”
Rafael Holdings, Inc. shareholders approved Election of Directors at the 2023-01-23 meeting.
“Nominee Votes For Votes Against Abstentions Broker Non-Vote % Votes For Stephen M. Greenberg 3,357,694 188,346 3,453 427,807 84.42”
David Polinsky was elected as Chief Financial Officer at Rafael Holdings, Inc..
“On January 4, 2023, the Board of Directors of the Company elected David Polinsky, the Company’s current Chief of Staff, as the Company’s Chief Financial Officer, effective January 28, 2023.”
Patrick Fabbio departed as Chief Financial Officer at Rafael Holdings, Inc..
“effective January 27, 2023, Mr. Fabbio, the current Chief Financial Officer of the Company, would be departing the Company.”
Rafael Holdings, Inc. reported the fiscal quarter ended October 31, 2022 results: net income $5.2 million, EPS $0.22 per share.
“For the three months ended October 31, 2022, we incurred a net loss from continuing operations of $5.2 million, or $0.22 per share”
Rafael Holdings, Inc. announced a restructuring with charges of approximately $0.5 million affecting early-stage development efforts, including pre-clinical research at the Barer Institute.
“On November 9, 2022, the Board of Directors of Rafael Holdings, Inc. (the “Company”) resolved to curtail its early-stage development efforts, including pre-clinical research at the Barer Institute. The decision was taken to reduce spending as the Company focuses on exploring strategic opportunities. The Company expects to incur severance charges in the amount of approximately $0.5 million.”
Rafael Holdings, Inc. reported the twelve months ended July 31, 2022 results: revenue $0.4 million, net income $122.8 million, EPS $6.22 per share.
“For the twelve months ended July 31, 2022, we incurred a net loss from continuing operations of $122.8 million or $6.22 per share, w hich includes an impairment of cost method investment and losses from loans and receivables from Cornerstone Pharmaceuticals, Inc. (formerly Rafael Pharmaceuticals, Inc.) totaling $114.2 million. For the same period in the prior year, we incurred a net loss from continuing operations of $22.8 million, or $1.38 per share which included $6.6 million in non-cash stock-based compensation expense. Our revenues from continuing operations for the twelve months ended July 31, 2022, amounted to $0.4 million compared to $0.8 million in the same period in the prior year.”
Rafael Holdings, Inc. reported the three months ended July 31, 2022 results: revenue $0.07 million, net income $4.6 million, EPS $0.24 per share.
“For the three months ended July 31, 2022, we incurred a net loss from continuing operations of $4.6 million, or $0.24 per share, which includes $1.2 million in non-cash stock-based compensation expense. For the same period in the prior year, we incurred a net loss from continuing operations of $12.2 million, or $0.75 per share, which included $5.6 million in non-cash stock-based compensation expense. Our revenues from continuing operations for the three months ended July 31, 2022, amounted to $0.07 million, compared to revenues of $0.19 million for the same period in the prior year.”
Ameet Mallik resigned as director at Rafael Holdings, Inc..
“On May 29, 2022, Ameet Mallik resigned as director of Rafael Holdings, Inc., effective immediately.”
Shannon Thyme Klinger resigned as director at Rafael Holdings, Inc..
“On May 24, 2022, Shannon Thyme Klinger resigned as director of Rafael Holdings, Inc., effective immediately.”
William Conkling was elected as Chief Executive Officer at Rafael Holdings, Inc..
“On January 19, 2022, the Board of Directors of Rafael Holdings, Inc. (the “Company”) elected William Conkling, the Company’s current Chief Commercial and Business Officer, as the Company’s Chief Executive Officer, effective February 1, 2022 and Mr. Conkling will no longer serve in his role as Chief Commercial and Business Officer.”
Patrick Fabbio was elected as President at Rafael Holdings, Inc..
“elected Patrick Fabbio, the Company’s Chief Financial Officer, as President in addition to his role as the Chief Financial Officer.”
William Conkling departed as Chief Commercial and Business Officer at Rafael Holdings, Inc..
“On November 21, 2021, the Board of Directors decided that William Conkling will depart as the Company’s Chief Commercial and Business Officer, effective January 31, 2022.”
Howard Jonas was elected as Chief Executive Officer at Rafael Holdings, Inc..
“On November 21, 2021, the Company’s Board of Directors (i) elected Howard Jonas, the Company’s Chairman of the Board, as the Company’s Chief Executive Officer, effective February 1, 2022”
Ameet Mallik resigned as Chief Executive Officer at Rafael Holdings, Inc..
“On November 21, 2021, Ameet Mallik resigned as Chief Executive Officer of Rafael Holdings, Inc. (the “Company”), effective January 31, 2022.”
Menachem Ash resigned as President and General Counsel at Rafael Holdings, Inc..
“On September 20, 2021, Menachem Ash voluntarily resigned as President and General Counsel of Rafael Holdings, Inc.”
Patrick Fabbio was elected as Chief Financial Officer at Rafael Holdings, Inc..
“On September 10, 2021, the Board of Directors of the Company elected Patrick Fabbio as the Chief Financial Officer effective September 13, 2021 (the “Start Date”).”
David Polinsky resigned as Chief Financial Officer at Rafael Holdings, Inc..
“On September 13, 2021, David Polinsky resigned as Chief Financial Officer of Rafael Holdings, Inc. (the “Company”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.